North America and Europe Acute Bacterial Skin and Skin Structure Infections (ABSSSI) Market, By Drug Type, By Infection Type, By Route of Administration, By Distribution Channel, By Geography

Description

North America And Europe Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Market is estimated to be valued at USD 1,615.5 Mn in 2026 and is expected to reach USD 2,111.7 Mn by 2033, growing at a compound annual growth rate (CAGR) of 5.5% from 2026 to 2033.

Report Coverage		Report Details
Base Year:	2025	Market Size in 2026:	USD 1,615.5 Mn
Historical Data for:	2020 To 2024	Forecast Period:	2026 To 2033
Forecast Period 2026 to 2033 CAGR:	5.50%	2033 Value Projection:	USD 2,111.7 Mn

Acute bacterial skin and skin structure infections (ABSSSI) are the skin and soft tissue infections that affect the epidermis, dermis, and subcutaneous tissues. The U.S. FDA defines ABSSSI as lesions with cellulitis/erysipelas, wound infections, and major cutaneous abscesses occurring in a minimum surface area of 75 cm2. Increasing number of ambulatory patients seeking treatment for skin and skin structure infections will further propel growth of the ABSSSI market. For instance, according to Decision Resource Group, in 2014, 11% of 2.7 million hospital admissions for ABSSSI were pediatric patients. The increasing pediatric patient pool is targeted by the manufacturers to enhance its product portfolio with pediatric specific products. For instance, in 2016, Allergan plc received US FDA approval for its supplemental New Drug Application (sNDA) for Teflaro, for ABSSSI indication in pediatric.

Market Dynamics

The major market driver for growth of North America and Europe Acute Bacterial Skin and Skin Structure Infections (ABSSSI) market is increasing research and development activities by pharmaceutical and biopharmaceutical companies to develop new products and novel treatment. For instance, in 2017, Cempra announced promising data from the phase 3 trial of Fusidic acid for the treatment of ABSSSI. In same year, Melinta Therapeutics received U.S. FDA for its product Baxdela, a delafloxacin based ABSSSI medicine, available in both intravenous and oral formulations. Moreover, in 2018, Fresenius Kabi received U.S. FDA approval for new drug application of daptomycin, a lipopeptide class of antibacterial drug, in injectable form for complicated skin and skin structure infections (cSSSI) caused by susceptible Gram-positive bacteria such as Staphylococcus aureus, Streptococcus pyogenes, Streptococcus agalactlae etc.

However, misuse of drugs causes antibiotic resistance which is a major factor hindering growth of the North America and Europe acute bacterial skin and skin structure infections (ABSSSI) market. For example, according to the Centers for Disease Control and Prevention data has shown that treatment indication, choice of agent, or duration of antibiotic therapy is incorrect in 30-50% of cases. Moreover, 30-60% of antibiotics prescribed in intensive care units (ICUs) have been found to be unnecessary, inappropriate, or suboptimal.

Key features of the study

It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by leading players
It profiles key players in the North America and Europe acute bacterial skin and skin structure infections (ABSSSI) market based on the following parameters - company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies
Key players covered as a part of this study are Merck & Co., Inc., Pfizer Inc., GlaxoSmithKline plc, Teva Pharmaceutical Industries Ltd., Paratek Pharmaceuticals, Inc., Melinta Therapeutics, Inc., Arrevus, Inc., AbbVie Inc., Aurobindo Pharma Ltd., Amneal Pharmaceuticals LLC, and Sun Pharmaceutical Industries Ltd.
Insights from this report would allow marketers and management authorities of companies to make informed decisions with respect to future product launches, governmental initiatives, technological up-gradation, market expansion, and marketing tactics
The North America and Europe acute bacterial skin and skin structure infections (ABSSSI) market report caters to various stakeholders in this industry, including investors, product manufacturers, distributors, and suppliers for North America and Europe acute bacterial skin and skin structure infections (ABSSSI) market, research and consulting firms, new entrants, and financial analysts.

North America and Europe Acute Bacterial Skin and Skin Structure Infections (ABSSSI) Market Segmentation

By Drug Type
- Oral & Parenteral Antibiotics
- Vancomycin
- Linezolid
- Clindamycin
- Ceftaroline
- Daptomycin
- Dalbavancin
- Tedizolid
- Others
- Topical Antibiotics
- Hydrogen Peroxide
- Fusidic Acid
- Mupirocin
- Retapamulin
- Povidone-Iodine
By Infection Type
- Hospital Acquired ABSSSI
- Community Acquired ABSSSI
By Route of Administration
- Oral
- Parenteral
- Topical
By Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
North America and Europe Acute Bacterial Skin and Skin Structure Infections (ABSSSI) Market, By Region
- North America
- U.S.
- Canada
- Europe
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
Key Players
- Merck & Co., Inc.
- Pfizer Inc.
- GlaxoSmithKline plc
- Teva Pharmaceutical Industries Ltd.
- Paratek Pharmaceuticals, Inc.
- Melinta Therapeutics, Inc.
- Arrevus, Inc.
- AbbVie Inc.
- Aurobindo Pharma Ltd.
- Amneal Pharmaceuticals LLC
- Sun Pharmaceutical Industries Ltd.

Product Code: CMI4273

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snapshot, By Drug Type
- Market Snapshot, By Infection Type
- Market Snapshot, By Route of Administration
- Market Snapshot, By Distribution Channel
- Market Snapshot, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Market Opportunities
Impact Analysis
Market Trends
Key Developments
Product Approval
Collaboration/Merge/Acquisition
Regulatory Landscape
PEST Analysis
Porter's Five Forces Analysis
Epidemiology
Robust Pipeline Analysis

4. North America and Europe Acute Bacterial Skin and Skin Structure Infections (ABSSSI) Market, By Drug Type, 2021 - 2033, (USD Mn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022- 2033
- Segment Trends
Oral & Parenteral Antibiotics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
  - Vancomycin
  - Linezolid
  - Clindamycin
  - Ceftaroline
  - Daptomycin
  - Dalbavancin
  - Tedizolid
  - Others
Topical Antibiotics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
  - Hydrogen Peroxide
  - Fusidic Acid
  - Mupirocin
  - Retapamulin
  - Povidone-Iodine

5. North America and Europe Acute Bacterial Skin and Skin Structure Infections (ABSSSI) Market, By Infection Type, 2021 - 2033, (USD Mn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
Hospital Acquired ABSSSI
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Community Acquired ABSSSI
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)

6. North America and Europe Acute Bacterial Skin and Skin Structure Infections (ABSSSI) Market, By Route of Administration, 2021 - 2033, (USD Mn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
Oral
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Parenteral
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Topical
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)

7. North America and Europe Acute Bacterial Skin and Skin Structure Infections (ABSSSI) Market, By Distribution Channel, 2021 - 2033, (USD Mn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
Hospital Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Online Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)

8. North America and Europe Acute Bacterial Skin and Skin Structure Infections (ABSSSI) Market, By Region, 2021 - 2033, (USD Mn)

Introduction
- Market Share Analysis, By Region, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, For Regions, 2022-2033
- Regional Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Infection Type, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Mn)
  - U.S.
  - Canada
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Infection Type, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Mn)
  - U.K.
  - Germany
  - Italy
  - France
  - Spain
  - Russia
  - Rest of Europe

9. Competitive Landscape

Heat Map Analysis
Market Share Analysis
Company Profile
- Merck & Co Inc
Company Highlights
Product Portfolio
Financial Performance
Recent Highlights
Market Strategies
- Pfizer Inc
Company Highlights
Product Portfolio
Financial Performance
Recent Highlights
Market Strategies
- GlaxoSmithKline plc
Company Highlights
Product Portfolio
Financial Performance
Recent Highlights
Market Strategies
- Teva Pharmaceutical Industries Ltd
Company Highlights
Product Portfolio
Financial Performance
Recent Highlights
Market Strategies
- Paratek Pharmaceuticals, Inc
Company Highlights
Product Portfolio
Financial Performance
Recent Highlights
Market Strategies
- Melinta Therapeutics, Inc.
Company Highlights
Product Portfolio
Financial Performance
Recent Highlights
Market Strategies
- Arrevus, Inc
Company Highlights
Product Portfolio
Financial Performance
Recent Highlights
Market Strategies
- AbbVie Inc
Company Highlights
Product Portfolio
Financial Performance
Recent Highlights
Market Strategies
- Aurobindo Pharma Ltd
Company Highlights
Product Portfolio
Financial Performance
Recent Highlights
Market Strategies
- Amneal Pharmaceuticals LLC
Company Highlights
Product Portfolio
Financial Performance
Recent Highlights
Market Strategies
- Sun Pharmaceutical Industries Ltd.
Company Highlights
Product Portfolio
Financial Performance
Recent Highlights
Market Strategies
Analyst Views

10. Section

References
Research Methodology
About Us